Reckitt Benckiser Group PLC (RKT), the FTSE-listed consumer health and hygiene company headquartered in Slough, has published its monthly voting rights and capital update in compliance with the FCA's Disclosure Guidance and Transparency Rules. As at 31 October 2026, the company confirms total voting rights of 633,277,467 ordinary shares, a figure shareholders and institutional investors must use as the denominator when calculating notification thresholds. The disclosure, made under DTR 5.6.1, reflects the suspension of voting rights attached to treasury shares held by the company.

Key Points

  • Reckitt Benckiser Group PLC (RKT), registered in England and Wales, No. 6270876
  • Total voting rights confirmed at 633,277,467 ordinary shares as at 31 October 2026
  • 674,005,752 ordinary shares in issue; 40,728,285 held in treasury with voting rights suspended
  • Investors holding or approaching FCA disclosure thresholds should recalculate their notification obligations using this updated denominator

Reckitt Benckiser's Issued Share Capital and Treasury Position at 31 October 2026

According to the announcement, Reckitt Benckiser Group plc had 674,005,752 issued ordinary shares of 10⁵⁄₁₂ pence each admitted to trading as at 31 October 2026. Each ordinary share carries one vote in all circumstances at general meetings. The company simultaneously held 40,728,285 ordinary shares of the same denomination in treasury, for which voting rights are automatically suspended under applicable legislation. Subtracting the treasury shares from the total issued share capital produces the disclosed total voting rights figure of 633,277,467, which the company has published in conformity with DTR 5.6.1.

How the 633,277,467 Denominator Affects Shareholder Disclosure Obligations

The primary purpose of this regulatory update is to provide shareholders and others with notification obligations the correct denominator for calculating whether their interests trigger disclosure requirements under the FCA's Disclosure Guidance and Transparency Rules. Any investor whose holding, when expressed as a percentage of 633,277,467, crosses a relevant threshold must notify the company accordingly. Reckitt Benckiser, a major constituent of the London market and maker of brands including Dettol, Nurofen, and Strepsils, operates across consumer health, hygiene, and nutrition categories globally, making its share register a focus for significant institutional interest.

Reckitt Benckiser's Regulatory Compliance and Company Secretarial Contact

The announcement was issued by Nikita Lawes, Deputy Company Secretary at Reckitt Benckiser Group plc, reachable at the company's registered address of 103–105 Bath Road, Slough, SL1 3UH. The company's Legal Entity Identifier (LEI) code is 5493003JFSMOJG48V108. Reckitt Benckiser is registered in England and Wales under company number 6270876. Routine monthly capital disclosures of this nature are a standard obligation for UK-listed companies under the DTR framework, ensuring transparency around the voting structure available to the market at any given point in time.